PT97062A - Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos - Google Patents
Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilosInfo
- Publication number
- PT97062A PT97062A PT97062A PT9706291A PT97062A PT 97062 A PT97062 A PT 97062A PT 97062 A PT97062 A PT 97062A PT 9706291 A PT9706291 A PT 9706291A PT 97062 A PT97062 A PT 97062A
- Authority
- PT
- Portugal
- Prior art keywords
- tenidap
- elastase
- neutrophilos
- libertacation
- inhibitor
- Prior art date
Links
- LXIKEPCNDFVJKC-QXMHVHEDSA-N tenidap Chemical compound C12=CC(Cl)=CC=C2N(C(=O)N)C(=O)\C1=C(/O)C1=CC=CS1 LXIKEPCNDFVJKC-QXMHVHEDSA-N 0.000 title abstract 4
- 229960003676 tenidap Drugs 0.000 title abstract 4
- 102000016387 Pancreatic elastase Human genes 0.000 title abstract 3
- 108010067372 Pancreatic elastase Proteins 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- IGPDWKCUDHIIRL-UHFFFAOYSA-N 5-chloro-2-oxo-3-[oxo(thiophen-2-yl)methyl]-3H-indole-1-carboxamide Chemical compound C12=CC(Cl)=CC=C2N(C(=O)N)C(=O)C1C(=O)C1=CC=CS1 IGPDWKCUDHIIRL-UHFFFAOYSA-N 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- 206010003230 arteritis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 201000001474 proteinuria Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/495,888 US5006547A (en) | 1990-03-19 | 1990-03-19 | Tenidap as an inhibitor of the release of elastase by neutrophils |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT97062A true PT97062A (pt) | 1991-10-31 |
| PT97062B PT97062B (pt) | 1998-07-31 |
Family
ID=23970396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97062A PT97062B (pt) | 1990-03-19 | 1991-03-18 | Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5006547A (pt) |
| EP (1) | EP0448261B1 (pt) |
| JP (1) | JPH0678230B2 (pt) |
| KR (1) | KR960016511B1 (pt) |
| AT (1) | ATE133071T1 (pt) |
| AU (1) | AU629109B2 (pt) |
| CA (1) | CA2038410C (pt) |
| DE (1) | DE69116404T2 (pt) |
| DK (1) | DK0448261T3 (pt) |
| HU (1) | HU212492B (pt) |
| IE (1) | IE70732B1 (pt) |
| IL (1) | IL97520A (pt) |
| MY (1) | MY107227A (pt) |
| NZ (1) | NZ237450A (pt) |
| PH (1) | PH27229A (pt) |
| PT (1) | PT97062B (pt) |
| ZA (1) | ZA911980B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008283A (en) * | 1990-03-19 | 1991-04-16 | Pfizer Inc. | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
| US5545656A (en) * | 1995-04-05 | 1996-08-13 | Pfizer Inc. | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease |
| US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| EP1390062A4 (en) * | 2001-05-02 | 2005-09-14 | Blood Res Center | MODULATORS OF ELASTASE INHIBITOR SECRETION |
| DK2026651T3 (da) | 2006-03-08 | 2013-07-08 | Cortria Corp | Kombinationsterapi med ikke-selektive COX-inhibitorer til forebyggelse af COX-relaterede maveskader |
| EP2886541A1 (en) * | 2013-12-19 | 2015-06-24 | Sanofi | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4678802A (en) * | 1985-07-09 | 1987-07-07 | Pfizer Inc. | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents |
| RO105052B1 (en) * | 1987-02-02 | 1994-12-01 | Pfizer | Producing process for the crystalline sodium salt, anhydre, of 5-chlorine-3-(2-tenoil)-2-oxindol-1-carboxamide |
| DE3852145T2 (de) * | 1987-02-18 | 1995-04-06 | Beecham Group Plc | Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten. |
| US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
| US4853409A (en) * | 1988-04-13 | 1989-08-01 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
| DE3814504A1 (de) * | 1988-04-29 | 1989-11-09 | Bayer Ag | (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1990
- 1990-03-19 US US07/495,888 patent/US5006547A/en not_active Expired - Lifetime
-
1991
- 1991-03-08 AT AT91301963T patent/ATE133071T1/de not_active IP Right Cessation
- 1991-03-08 DK DK91301963.4T patent/DK0448261T3/da active
- 1991-03-08 PH PH42109A patent/PH27229A/en unknown
- 1991-03-08 DE DE69116404T patent/DE69116404T2/de not_active Expired - Fee Related
- 1991-03-08 EP EP91301963A patent/EP0448261B1/en not_active Expired - Lifetime
- 1991-03-12 IL IL9752091A patent/IL97520A/en not_active IP Right Cessation
- 1991-03-15 IE IE86191A patent/IE70732B1/en not_active IP Right Cessation
- 1991-03-15 NZ NZ237450A patent/NZ237450A/en unknown
- 1991-03-15 CA CA002038410A patent/CA2038410C/en not_active Expired - Fee Related
- 1991-03-18 PT PT97062A patent/PT97062B/pt not_active IP Right Cessation
- 1991-03-18 ZA ZA911980A patent/ZA911980B/xx unknown
- 1991-03-18 KR KR1019910004237A patent/KR960016511B1/ko not_active Expired - Fee Related
- 1991-03-18 HU HU91871A patent/HU212492B/hu not_active IP Right Cessation
- 1991-03-18 AU AU73586/91A patent/AU629109B2/en not_active Ceased
- 1991-03-18 MY MYPI91000439A patent/MY107227A/en unknown
- 1991-03-19 JP JP3130751A patent/JPH0678230B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04234814A (ja) | 1992-08-24 |
| EP0448261A3 (en) | 1992-04-08 |
| JPH0678230B2 (ja) | 1994-10-05 |
| NZ237450A (en) | 1997-02-24 |
| ZA911980B (en) | 1992-10-28 |
| CA2038410C (en) | 1995-01-24 |
| KR910016327A (ko) | 1991-11-05 |
| US5006547A (en) | 1991-04-09 |
| IL97520A (en) | 1995-12-31 |
| PT97062B (pt) | 1998-07-31 |
| EP0448261B1 (en) | 1996-01-17 |
| HUT60622A (en) | 1992-10-28 |
| DK0448261T3 (da) | 1996-02-12 |
| DE69116404T2 (de) | 1996-05-30 |
| HU212492B (en) | 1996-07-29 |
| IL97520A0 (en) | 1992-06-21 |
| AU7358691A (en) | 1992-08-06 |
| DE69116404D1 (de) | 1996-02-29 |
| IE70732B1 (en) | 1996-12-11 |
| ATE133071T1 (de) | 1996-02-15 |
| PH27229A (en) | 1993-05-04 |
| MY107227A (en) | 1995-10-31 |
| KR960016511B1 (ko) | 1996-12-14 |
| EP0448261A2 (en) | 1991-09-25 |
| IE910861A1 (en) | 1991-09-25 |
| AU629109B2 (en) | 1992-09-24 |
| HU910871D0 (en) | 1991-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69435118D1 (de) | Gereinigte Zusammensetzungen von Newcastle-Krankheitvirus | |
| PT627221E (pt) | Substancias antagonistas p para o tratamento de emese | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| ATE225341T1 (de) | In 6-position durch thio substituierte paclitaxele | |
| FI901085A0 (fi) | Biosidisia koostumuksia ja menetelmiä, joissa niitä käytetään | |
| DE69010162D1 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
| BR9205142A (pt) | Composicao inseticida,e,processo para produzi-la | |
| AR244492A1 (es) | Composicion fungicida mejorada para el tratamiento de la madera. | |
| RU94031161A (ru) | Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов | |
| NO900612L (no) | Preservativ for vandige sammensetninger. | |
| DK0448261T3 (da) | Tenidap som inhibitor for neutrofilers frigørelse af elastase | |
| CO5221050A1 (es) | Composicion limpiadora que comprende un depurados de radicales, para limpieza eficaz y estabilidad mejorada en almacenamiento | |
| BR9102635A (pt) | Derivado de pirazolcarboxamida,composicao fungicida e acaricida e processo para produzir derivado de pirazolcarboxamida | |
| BR9813357A (pt) | Composição de barra, e, processo para fornecer atividade bacteriostática | |
| MX9205257A (es) | Dihidropiridinas substituidas por indolsulfonamida y procedimiento para su fabricacion. | |
| DK0471040T3 (da) | Anvendelse af cromakalim/BRL 38227 til behandling af hyperreaktivitet i luftveje | |
| SE9202434D0 (sv) | Skatolinaktiverande komposition | |
| AR013096A1 (es) | Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma. | |
| ES1022616Y (es) | Dado para juegos. | |
| ES521091A0 (es) | Mejoras en el objeto de la patente principal no 513.956 por procedimiento para la carbonilacion de olefinas y esteres organicos. | |
| ES1014974Y (es) | Punta de anclaje para varillas en taladros practicados en tableros o piezas de madera. | |
| ES512654A0 (es) | "mejoras introducidas en el objeto de la patente principal n 497.716, por: perfeccionamientos introducidos en las correderas sencillas o de giro para lama verticales". | |
| BR6900022U (pt) | Piano de reforma tecnica e financeira para o futebol | |
| ITVC970001U4 (it) | Regolo di calcolo per il gioco del lotto. | |
| ES2025787T3 (es) | Procedimiento de tratamiento de madera. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19910710 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19980417 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19991031 |